SEC Filing Summary for Linda West - Context Therapeutics Inc.

Linda West, a director at Context Therapeutics Inc. (CNTX), was granted 45,000 stock options on June 24, 2026. These options have an exercise price of $0.576 and an expiration date of June 23, 2036. The options vest and become exercisable on the earlier of June 24, 2027, or the Issuer's 2027 annual meeting of stockholders, provided West continues her service with the company. Following this transaction, West holds 45,000 shares of common stock underlying these options.